The Innovative Medicines Initiative (IMI) is the world’s largest public private partnership with a €5 Billion budget. For three years, Pierre Meulien has been the IMI’s Executive Director, bringing with him a wealth of international experience including a stint as the head of Genome Canada and founding Molecular Medicine Ireland. In this podcast we discuss the challenges of European healthcare, the evolution of the IMI since his appointment, and the role the IMI should play in Horizon Europe with the next commission.See omnystudio.com/listener for privacy information.
Top comments
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.